Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 358121 - 358140 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Poland | (L01AX03) temozolomide | Temozolomide Sun, kapsułki twarde, 180 mg | 5 szt., 180 mg , 5 kaps. | Wholesale price with vat |
$0-0 |
$0-0 |
Glioma; Glioblastoma | SunPharmaceuticalIndustriesEuropeB.V. |
| Poland | (L01AX03) temozolomide | Temozolomide Sun, kapsułki twarde, 20 mg | 5 szt., 20 mg , 5 kaps. | Wholesale price with vat |
$0-0 |
$0-0 |
Glioma; Glioblastoma | SunPharmaceuticalIndustriesEuropeB.V. |
| Poland | (L01AX03) temozolomide | Temozolomide Sun, kapsułki twarde, 250 mg | 5 szt., 250 mg , 5 kaps. | Wholesale price with vat |
$0-0 |
$0-0 |
Glioma; Glioblastoma | SunPharmaceuticalIndustriesEuropeB.V. |
| Poland | (L01AX03) temozolomide | Temozolomide Sun, kapsułki twarde, 5 mg | 5 szt., 5 mg , 5 kaps. | Wholesale price with vat |
$0-0 |
$0-0 |
Glioma; Glioblastoma | SunPharmaceuticalIndustriesEuropeB.V. |
| Poland | (L01BA01) methotrexate | Methofill SD, roztwór do wstrzykiwań we wstrzykiwaczu, 15 mg | 8 wstrzykiwaczy, 15 mg , 8 wstrzykiwacze 0,3 ml | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcarePolskaSp.zo.o. |
| Poland | (L01BA04) pemetrexed | Pemetrexed Fresenius Kabi, koncentrat do sporządzania roztworu do infuzji, 25 mg/ml | 1 fiol. 4 ml, 25 mg/ml , 1 fiol. 4 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Mesothelioma | FreseniusKabiDeutschlandGmbH |
| Poland | (L01BA04) pemetrexed | Pemetrexed Fresenius Kabi, koncentrat do sporządzania roztworu do infuzji, 25 mg/ml | 1 fiol. 40 ml, 25 mg/ml , 1 fiol. 40 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Mesothelioma | FreseniusKabiDeutschlandGmbH |
| Poland | (L01BA04) pemetrexed | Pemetrexed Fresenius Kabi, koncentrat do sporządzania roztworu do infuzji, 25 mg/ml | 1 fiol. 20 ml, 25 mg/ml , 1 fiol. 20 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Mesothelioma | FreseniusKabiDeutschlandGmbH |
| Poland | (L01CA02) vincristine | Vincristine Teva, roztwór do wstrzykiwań, 1 mg/ml | 1 fiol.po 1 ml, 1 mg/ml , 1 fiol. 1 ml | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsPolskaSp.zo.o. |
| Poland | (L01CA02) vincristine | Vincristine Teva, roztwór do wstrzykiwań, 1 mg/ml | 1 fiol.po 5 ml, 1 mg/ml , 1 fiol. 5 ml | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsPolskaSp.zo.o. |
| Poland | (L01EA02) dasatinib | Sprycel, tabl. powl., 100 mg | 30 szt., 100 mg , 1 butelka 30 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01EA02) dasatinib | Sprycel, tabl. powl., 140 mg | 30 szt., 140 mg , 1 butelka 30 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01EA02) dasatinib | Sprycel, tabl. powl., 20 mg | 60 szt., 20 mg , 1 butelka 60 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01EA02) dasatinib | Sprycel, tabl. powl., 50 mg | 60 szt., 50 mg , 1 butelka 60 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01EA02) dasatinib | Sprycel, tabl. powl., 80 mg | 30 szt., 80 mg , 1 butelka 30 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01EH01) lapatinib | Brastib, tabl. powl., 250 mg | 140 szt., 250 mg , 2 op. 70 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | STADAArzneimittelAG |
| Poland | (L01EX12) larotrectinib | Vitrakvi, kaps. twarde, 100 mg | 56 szt., 100 mg , 1 butelka 56 kaps. | Wholesale price with vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAG |
| Poland | (L01FD01) trastuzumab | Zercepac, proszek do sporządzania koncentratu roztworu do infuzji, 150 mg | 1 fiol., 150 mg , 1 fiol. 150 mg proszku | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Stomach Neoplasms | AccordHealthcareS.L.U. |
| Poland | (L01FD01) trastuzumab | Zercepac, proszek do sporządzania koncentratu roztworu do infuzji, 420 mg | 1 fiol., 420 mg , 1 fiol. 420 mg proszku | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Stomach Neoplasms | AccordHealthcareS.L.U. |
| Poland | (L01XA01) cisplatin | Cisplatinum Accord, koncentrat do sporządzania roztworu do infuzji, 1 mg/ml | 1 fiol. a 10 ml, 1 mg/ml , 1 fiol. 10 ml | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcarePolskaSp.zo.o. |
Pages
